These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19489695)

  • 1. From proteomics research to clinical practice.
    Tsangaris GT
    Expert Rev Proteomics; 2009 Jun; 6(3):235-8. PubMed ID: 19489695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on the 1st International Conference of the Hellenic Proteomics Society in Athens, Greece.
    Fountoulakis M; Vlahou A
    Proteomics; 2005 Sep; 5(14):3556-7. PubMed ID: 16127734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Proteomics: Closing the Gap from Discovery to Implementation.
    Frantzi M; Latosinska A; Kontostathi G; Mischak H
    Proteomics; 2018 Jul; 18(14):e1700463. PubMed ID: 29785737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic landscape in Central and Eastern Europe: the 9th Central and Eastern European Proteomic Conference, Poznań, Poland.
    Gadher SJ; Marczak Ł; Łuczak M; Stobiecki M; Widlak P; Kovarova H
    Expert Rev Proteomics; 2016; 13(1):5-7. PubMed ID: 26558656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synopsis of the 3rd annual Cancer Proteomics Conference.
    Mesri M; Kinsinger C; Boja E; Hiltke T; Rahbar A; Rivers R; Rodriguez H
    Expert Rev Proteomics; 2010 Dec; 7(6):815-7. PubMed ID: 21142883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2nd Combined Working Group and Management Committee Meeting of Urine and Kidney Proteomics COST Action 29-30 March 2009, Nafplio, Greece.
    Vlahou A; Allmaier G; Attwood T; Bongcam-Rudloff E; Charonis A; Frokiaer J; Mischak H; Schanstra J; Spasovski G
    Proteomics Clin Appl; 2009 Sep; 3(9):1017-22. PubMed ID: 21137004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics: a new diagnostic frontier.
    Hortin GL; Jortani SA; Ritchie JC; Valdes R; Chan DW
    Clin Chem; 2006 Jul; 52(7):1218-22. PubMed ID: 16675505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application.
    Lehmann S; Hoofnagle A; Hochstrasser D; Brede C; Glueckmann M; Cocho JA; Ceglarek U; Lenz C; Vialaret J; Scherl A; Hirtz C;
    Clin Chem Lab Med; 2013 May; 51(5):919-35. PubMed ID: 23183755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based proteome analysis: the first stage in the pipeline for biomarker discovery.
    Poschmann G; Sitek B; Sipos B; Hamacher M; Vonend O; Meyer HE; Stühler K
    Biochim Biophys Acta; 2009 Sep; 1794(9):1309-16. PubMed ID: 19595794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
    Clarke W; Chan DW
    Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteomic technology and its biomedical applications.
    Lau AT; He QY; Chiu JF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important options available--from start to finish--for translating proteomics results to clinical chemistry.
    Heegaard NH; Østergaard O; Bahl JM; Overgaard M; Beck HC; Rasmussen LM; Larsen MR
    Proteomics Clin Appl; 2015 Feb; 9(1-2):235-52. PubMed ID: 25472910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free quantification in clinical proteomics.
    Megger DA; Bracht T; Meyer HE; Sitek B
    Biochim Biophys Acta; 2013 Aug; 1834(8):1581-90. PubMed ID: 23567906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
    Kim SH; Weiß C; Hoffmann U; Borggrefe M; Akin I; Behnes M
    Curr Pharm Biotechnol; 2017; 18(6):445-455. PubMed ID: 28571562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in mass spectrometry proteomics for biomedical research.
    Li X; Wang W; Chen J
    Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine as a source for clinical proteome analysis: from discovery to clinical application.
    Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
    Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in modern biomarker discovery--17th HUPO BPP workshop: May 24-25, 2012, Sao Paulo, Brazil.
    Gröttrup B; Esselmann H; May C; Schrötter A; Woitalla D; Heinsen H; Marcus K; Wiltfang J; Meyer HE; Grinberg LT; Park YM
    Proteomics; 2013 Jan; 13(2):210-6. PubMed ID: 23341064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.